Results 141 to 150 of about 20,735 (212)

Stevens-Johnson syndrome after ChAdOx1 nCoV-19 vaccine

Indian Journal of Dermatology, Venereology and Leprology, 2022
Pedro Alves, da Cruz Gouveia, Larissa N F, Cavalcanti, Lucas C F, Alves, Daniel M, Almeida, Lucília Willa A, Barretto   +4 more
openaire   +2 more sources

Post ChAdOx1 nCoV-19 vaccination frontal lobe syndrome

Neurological Sciences, 2022
Madhusudan Tapdia, Anand Kumar, Varun Kumar Singh, Abhishek Pathak, Deepika Joshi   +4 more
openaire   +2 more sources

Erythrodermic psoriasis following ChAdOx1 nCOV-19 vaccination

Dermatologica Sinica, 2022
Pei-Tzu Lin, Ching-Chi Chi
openaire   +2 more sources

Rational Design of a Chimpanzee Adenoviral-Vector Vaccine Against Yellow Fever Through the Modification of Antigen Transmembrane Domains. [PDF]

Vaccines (Basel)
Ulaszewska M, Ma J, Morris SJ, Jegouic Goodall SM, Kerstens W, Thibaut HJ, Coelmont L, Dallmeier K, Gilbert SC, Dema B.   +9 more
europepmc   +1 more source

Development and Evaluation of Compact Semi-Synthetic Promoters for Enhanced Antigen Expression in Adenoviral-Vectored Vaccines. [PDF]

Vaccines (Basel)
Hlaváč M, Morris SJ, Dema B, Ulaszewska M, Al-Hareth Z, Douradinha B, Gilbert SC.   +6 more
europepmc   +1 more source

Replication-incompetent viral vaccine vectors ChAdOx1 and MVA as tools for evaluating T-cell responses to naturally processed antigens in vitro. [PDF]

Virus Res
Nazki S, Reiné J, Kailath R, Gilbert S, Douradinha B.   +4 more
europepmc   +1 more source

Hematologic adverse events following COVID-19 vaccination and revaccination in persons aged 12 and above: A Canadian Immunization Research Network study. [PDF]

Hum Vaccin Immunother
Smolinski M, Chew JL, Constantinescu C, Buchan CA, Burton C, Carignan A, Castellucci LA, Suresh S, McConnell A, Morris SK, Naus M, Pernica JM, Pham-Huy A, Piche-Renaud PP, Sadarangani M, Top KA, Cowan J, Special Immunization Clinic Network investigators.   +17 more
europepmc   +1 more source

Temporal dynamics of SARS-CoV-2 antibodies and IgG subclasses following multiple doses and diverse COVID-19 vaccine combinations. [PDF]

Front Immunol
Meyer J, Hoerauf A, Dubiel AE, Kovačević P, Trudić A, Primorac D, Hübner MP, Adjobimey T, Parcina M.   +8 more
europepmc   +1 more source

Fractional BNT162b2 boosters induce durable immune responses after non-mRNA priming in Mongolia: a randomised controlled trial. [PDF]

Front Immunol
Batmunkh T, Neal EF, Amraa O, Mazarakis N, Altangerel B, Avaa N, Batbayar L, Batsukh K, Bright K, Burentogtokh T, Do LAH, Dorj G, Hart JD, Jamiyandorj O, Javkhlantugs K, Jigjidsuren S, Justice F, Li S, Mashbaatar K, Moore KA, Namjil N, Nguyen CD, Ochirbat B, Surenjav U, Thomson H, Tsolmon B, Licciardi PV, von Mollendorf C, Mulholland K.   +28 more
europepmc   +1 more source

Steven Johnson Syndrome Following ChAdOx1 nCoV-19 Vaccination (AstraZeneca)

Annals of Dermatology, 2023
Hyo Jin Lee, So Yeon Yun, Jin Young Choi, Young Bok Lee   +3 more
openaire   +2 more sources